论文部分内容阅读
目的:探讨盐酸氨溴索在小儿支气管肺炎治疗中的应用价值。方法:在医院2014年10月到2015年7月期间诊治的支气管肺炎患儿中抽取74例作研究对象,利用随机抽样法将其分为观察组(n=37)和对照组(n=37),观察组在综合对症治疗基础上应用盐酸氨溴索治疗,对照组则单纯采取综合对症治疗,对比两组患儿的治疗效果和呼吸频率变化。结果:观察组治疗总有效率为97.3%,高于对照组的78.4%;同时,观察组治疗后的呼吸频率是(23±9)次/min,明显低于对照组的(37±11)次/min,上述比较差异均有统计学意义(P<0.05)。结论:盐酸氨溴索在小儿支气管肺炎治疗中的应用价值显著,在缓解患儿临床症状上作用明显。
Objective: To investigate the value of ambroxol hydrochloride in the treatment of bronchial pneumonia in children. Methods: Totally 74 children with bronchial pneumonia diagnosed and treated during the period from October 2014 to July 2015 in our hospital were selected as study subjects and divided into observation group (n = 37) and control group (n = 37) by random sampling method ). The observation group was treated with Ambroxol Hydrochloride on the basis of comprehensive symptomatic treatment, while the control group was treated by comprehensive symptomatic treatment. The treatment effect and respiratory rate of the two groups were compared. Results: The total effective rate of the observation group was 97.3%, which was higher than that of the control group (78.4%). Meanwhile, the respiratory rate of the observation group was (23 ± 9) / min, which was significantly lower than that of the control group (37 ± 11) Times / min, the above differences were statistically significant (P <0.05). Conclusion: Ambroxol Hydrochloride in children with bronchial pneumonia in the treatment of significant value in the treatment of children with clinical symptoms significantly.